Search Results - "Colhoun, Helen"

Treatment Outcomes of Cognitive Behavioural Therapy for Earthquake‐Related Distress.

Authors: Woods, Cate F. McIntosh, Virginia V. W. Frampton, Christopher M. et al.

Source: Counselling & Psychotherapy Research. Mar2025, Vol. 25 Issue 1, p1-12. 12p.

Subjects: Treatment of post-traumatic stress disorder, Fear, Psychological distress, Mental health services, Mental illness, Treatment effectiveness, Anxiety, Adjustment disorders, Aggression (Psychology), Psychological stress, Social adjustment, Cognitive therapy, Natural disasters, Mental depression, Adults

Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial.

Authors: Deanfield, John Lincoff, A Michael Kahn, Steven E et al.

Source: Lancet. Nov2025, Vol. 406 Issue 10516, p2257-2268. 12p.

Subjects: Semaglutide, Major adverse cardiovascular events, Clinical trials, Obesity, Weight loss, Waist circumference

Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT): Outcomes by Sex.

Authors: Verma, Subodh Colhoun, Helen M. Dicker, Dror et al.

Source: Journal of the American College of Cardiology (JACC). Oct2024, Vol. 84 Issue 17, p1678-1682. 5p.

Does a disaster worsen anxiety when you are already anxious? Psychological consequences following exposure to a M7.1 earthquake in an outpatient anxiety disorder population.

Authors: Kannis-Dymand, Lee Colhoun, Helen Huntley, Monique et al.

Source: Australasian Journal of Disaster & Trauma Studies. Aug2022, Vol. 26 Issue 1, p3-13. 11p.

Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial.

Authors: Deanfield, John Verma, Subodh Scirica, Benjamin M et al.

Source: Lancet. Aug2024, Vol. 404 Issue 10454, p773-786. 14p.

Subjects: Heart failure, Major adverse cardiovascular events, Coronary artery disease, Clinical trials, Heart failure patients, Myocardial infarction

Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol.

Authors: Colhoun, Helen M. Leiter, Lawrence A. Müller-Wieland, Dirk et al.

Source: Cardiovascular Diabetology. 2/8/2020, Vol. 19 Issue 1, p1-11. 11p. 1 Diagram, 2 Charts, 2 Graphs.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Relevance of Quantitative Measures of Beta-Cell Function in Clinical Practice.

Authors: Galderisi, Alfonso Dayan, Colin M. Colhoun, Helen M. et al.

Source: Hormone Research in Paediatrics. May2026, p1-15. 15p. 3 Illustrations.

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

Authors: Colhoun HM Betteridge DJ Durrington PN et al.

Source: Lancet. 8/21/2004, Vol. 364 Issue 9435, p685-696. 12p.

Problems of reporting genetic associations with complex outcomes.

Authors: Colhoun HM McKeigue PM Smith GD et al.

Source: Lancet. 3/8/2003, Vol. 361 Issue 9360, p865-872. 8p.

Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics.

Authors: Lingvay, Ildiko Brown‐Frandsen, Kirstine Colhoun, Helen M. et al.

Source: Obesity (19307381). Jan2023, Vol. 31 Issue 1, p111-122.

Effectiveness of Group Cognitive Therapy for Social Anxiety Disorder in Routine Care.

Authors: Colhoun, Helen Kannis-Dymand, Lee Rudge, Marion et al.

Source: Behaviour Change. Jun2021, Vol. 38 Issue 2, p60-72. 13p.

Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications.

Authors: Jeyam, Anita Colhoun, Helen McGurnaghan, Stuart et al.

Source: Diabetes Care. Feb2021, Vol. 44 Issue 2, p390-398. 9p.

EFFECT OF THE GLP-1 RECEPTOR AGONIST SEMAGLUTIDE ON TOTAL CARDIOVASCULAR EVENTS IN PATIENTS WITH CARDIOVASCULAR DISEASE AND OVERWEIGHT OR OBESITY BUT NO DIABETES IN THE SELECT TRIAL.

Authors: Lincoff, Abraham Michael Colhoun, Helen Emerson, Scott et al.

Source: Journal of the American College of Cardiology (JACC). 2025 Supplement, Vol. 85 Issue 12, p378-378. 1p.

Reservoir Pressure Integral Is Independently Associated With the Reduction in Renal Function in Older Adults.

Authors: Aizawa, Kunihiko Hughes, Alun D. Casanova, Francesco et al.

Source: Hypertension (0194911X). Oct2022, Vol. 79 Issue 10, p2364-2372.

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.

Authors: Gerstein, Hertzel C Colhoun, Helen M Dagenais, Gilles R et al.

Source: Lancet. Jul2019, Vol. 394 Issue 10193, p121-130. 10p.

Subjects: Stroke prevention, Cardiovascular disease prevention, Cardiovascular disease related mortality, Therapeutic use of immunoglobulins, Myocardial infarction, Evaluation research, Research funding, Blind experiment, Hypoglycemic agents, Randomized controlled trials, Glucagon-like peptides, Recombinant proteins, Type 2 diabetes, Research methodology, Research, Comparative studies, Disease complications

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.

Authors: Gerstein, Hertzel C Colhoun, Helen M Dagenais, Gilles R et al.

Source: Lancet. Jul2019, Vol. 394 Issue 10193, p131-138. 8p.

Subjects: Type 2 diabetes, Glomerular filtration rate, Glucagon-like peptide-1 agonists, Subcutaneous injections, Myocardial infarction, Therapeutic use of immunoglobulins, Recombinant proteins, Hypoglycemic agents, Albuminuria, Comparative studies, Creatinine, Diabetic nephropathies, Research methodology, Medical cooperation, Research, Evaluation research, Randomized controlled trials, Blind experiment, Glucagon-like peptides, Therapeutics

After FIELD: should fibrates be used to prevent cardiovascular disease in diabetes.

Authors: Colhoun, Helen

Source: Lancet. 11/26/2005, Vol. 366 Issue 9500, p1829-1831. 3p.

Subjects: Type 2 diabetes, Diabetes, Antilipemic agents, Endocrine diseases, Coronary disease, Lancet, The (Periodical), Medical research

Reservoir-Excess Pressure Parameters Independently Predict Cardiovascular Events in Individuals With Type 2 Diabetes.

Authors: Aizawa, Kunihiko Casanova, Francesco Gates, Phillip E. et al.

Source: Hypertension (0194911X). Jul2021, Vol. 78 Issue 1, p40-50.